- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Devyser Diagnostics AB (DVYSR)
The Devyser Diagnostics AB share price today is 96.50, view ST DVYSR stock exchange data. Track the latest Devyser Diagnostics AB share price with real-time updates on DVYSR stock performance including market cap, day range, 52-week range and dividend yield. Access DVYSR charts, earnings dates and analyst estimates to support your investment decisions.
Stockholm
Currency in SEK
96.50
+1.50(+1.58%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
94.90
97.80
52 wk Range
74.00
159.60
DVYSR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
94.9097.80
52 wk Range
74.00159.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DVYSR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
151.85
Upside
+57.36%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 151.85
(+57.36% Upside)
Devyser Diagnostics AB Earnings Call Summary for Q1/2026
- Q1 2026 revenue rose 13% YoY to SEK 62M; EBIT turned positive at SEK 2.6M, marking fourth consecutive profitable quarter vs SEK -14.8M loss in Q1 2025.
- Gross margin held strong at 81.6% with operating cash flow of SEK 12M; stock price climbed 3.24% to SEK 92.4 on earnings announcement.
- New IVDR product launches and strategic partnerships with Illumina and Thermo Fisher drove test volume growth and expanded market presence.
- Company expects stronger Q2 and Q4 performance; analysts forecast FY2026 EPS of $0.26 with continued revenue growth from strategic collaborations.
- Key risks include currency headwinds from strong SEK, Middle East supply chain disruptions, regulatory compliance, and competitive pressures in diagnostics.
Last Updated: 27-04-2026, 03:06 pm
Read Full TranscriptEarnings
Latest Release
27-04-2026
EPS / Forecast
0.17 / 0.04
Revenue / Forecast
61.8M / 63.7M
Compare DVYSR to Peers and Sector
Metrics to compare | DVYSR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDVYSRPeersSector | |
|---|---|---|---|---|
P/E Ratio | 106.9x | −2.2x | −0.5x | |
PEG Ratio | 0.88 | −0.56 | 0.00 | |
Price/Book | 4.5x | 2.5x | 2.6x | |
Price / LTM Sales | 6.2x | 4.3x | 3.1x | |
Upside (Analyst Target) | 58.7% | 61.1% | 53.0% | |
Fair Value Upside | Unlock | 6.0% | 6.3% | Unlock |
Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Devyser Diagnostics AB (DVYSR) Share Price Today?
The Devyser Diagnostics AB share price today is 96.50.
What is the current Devyser Diagnostics AB (DVYSR) share price and day range?
As of 22-05-2026, the Devyser Diagnostics AB share price is 96.50, with a previous close of 95.00. The share price has ranged from 94.90 to 97.80 today, while the 52-week range spans from 74.00 to 159.60.
What Is the Devyser Diagnostics AB Market Cap?
As of today, Devyser Diagnostics AB market cap is 1.62B.
What Is the Devyser Diagnostics AB (DVYSR) Share Price Target?
The average 12-month share price target for Devyser Diagnostics AB is 151.85, with a high estimate of 164.63414634 and a low estimate of 140.54152149. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +57.36% Upside potential.
What Is Devyser Diagnostics AB's Earnings Per Share (TTM)?
The Devyser Diagnostics AB EPS (TTM) is 0.89.
When Is the Next Devyser Diagnostics AB Earnings Date?
Devyser Diagnostics AB will release its next earnings report on 20-07-2026.
From a Technical Analysis Perspective, Is DVYSR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Devyser Diagnostics AB Trade On?
Devyser Diagnostics AB is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Devyser Diagnostics AB?
The stock symbol for Devyser Diagnostics AB is "DVYSR."
How Many Times Has Devyser Diagnostics AB Stock Split?
Devyser Diagnostics AB has split 0 times.
How Many Employees Does Devyser Diagnostics AB Have?
Devyser Diagnostics AB has 110 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.